5,305
Views
4
CrossRef citations to date
0
Altmetric
Review

Effects of influenza immunization on pneumonia in the elderly

, ORCID Icon, , , , , & show all
Pages 744-749 | Received 07 Sep 2017, Accepted 08 Nov 2017, Published online: 19 Dec 2017

References

  • Nicholson KG. Human Influenza. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of Influenza. Oxford: Blackwell Science; 1998. p.219–264.
  • Ballinger MN, Standiford TJ. Postinfluenza bacterial pneumonia: host defenses gone awry. J Interferon Cytokine Res. 2010;30:643–652. doi:10.1089/jir.2010.0049. PMID:20726789.
  • American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416. doi:10.1164/rccm.200405-644ST. PMID:15699079
  • Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis. 2000;181:831–837. doi:10.1086/315320. PMID:10720501
  • Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–186. doi. doi:10.1001/jama.289.2.179. PMID:12517228
  • Metersky ML, Masterton RG, Lode H, File TM, Jr., Babinchak T. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int J Infect Dis. 2012;16:e321–331. doi:10.1016/j.ijid.2012.01.003.
  • Bui C, Bethmont A, Chughtai AA, Gardner L, Sarkar S, Hassan S, Seale H, MacIntyre CR. A Systematic Review of the Comparative Epidemiology of Avian and Human Influenza A H5N1 and H7N9 – Lessons and Unanswered Questions. Transbound Emerg Dis. 2016;63:602–620. doi:10.1111/tbed.12327. PMID:25644240
  • McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol. 2014;12:252–262. doi:10.1038/nrmicro3231. PMID:24590244
  • Metzger DW, Sun K. Immune dysfunction and bacterial coinfections following influenza. J Immunol. 2013;191:2047–2052. doi: 10.4049/jimmunol.1301152. doi:10.4049/jimmunol.1301152. PMID:23964104
  • Song JY, Cheong HJ, Heo JY, Noh JY, Yong HS, Kim YK, Kang EY, Choi WS, Jo YM, Kim WJ. Clinical, laboratory and radiologic characteristics of 2009 pandemic influenza A/H1N1 pneumonia: primary influenza pneumonia versus concomitant/secondary bacterial pneumonia. Influenza Other Respir Viruses. 2011;5:e535–543. doi:10.1111/j.1750-2659.2011.00269.x. PMID:21682848
  • Choi WS, Baek JH, Seo YB, Kee SY, Jeong HW, Lee HY, Eun BW, Choo EJ, Lee J, Kim YK, et al. Severe influenza treatment guideline. Korean J Intern Med. 2014;29:132–147. doi:10.3904/kjim.2014.29.1.132.
  • Fukuyama S, Kawaoka Y. The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol. 2011;23:481–486. doi:10.1016/j.coi.2011.07.016.
  • Song JY, Nahm MH, Cheong HJ, Kim WJ. Impact of preceding flu-like illness on the serotype distribution of pneumococcal pneumonia. PLoS One. 2014;9:e93477. doi:10.1371/journal.pone.0093477. PMID:24691515
  • Song JY, Lee JS, Wie SH, Kim HY, Lee J, Seo YB, Jeong HW, Kim SW, Lee SH, Park KH, et al. Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization. Clin Vaccine Immunol. 2015;22:229–234. doi:10.1128/CVI.00673-14. PMID:25540271
  • Kang SH, Cheong HJ, Song JY, Noh JY, Jeon JH, Choi MJ, Lee J, Seo YB, Lee JS, Wie SH, et al. Analysis of Risk Factors for Severe Acute Respiratory Infection and Pneumonia and among Adult Patients with Acute Respiratory Illness during 2011–2014 Influenza Seasons in Korea. Infect Chemother. 2016;48:294–301. doi:10.3947/ic.2016.48.4.294. PMID:27883375
  • Domnich A, Arata L, Amicizia D, Puig-Barbera J, Gasparini R, Panatto D. Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis. Vaccine. 2017;35:513–520. doi:10.1016/j.vaccine.2016.12.011. PMID:28024956
  • Chan TC, Fan-Ngai Hung I, Ka-Hay Luk J, Chu LW, Hon-Wai Chan F. Effectiveness of influenza vaccination in institutionalized older adults: a systematic review. J Am Med Dir Assoc. 2014;15:226.e221–226. doi:10.1016/j.jamda.2013.10.008.
  • Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2010;doi:10.1002/14651858.CD004876.pub3.Cd004876.
  • Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine. 2002;20:1831–1836. doi. doi:10.1016/S0264-410X(02)00041-5. PMID:11906772
  • Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518–527. doi. doi:10.7326/0003-4819-123-7-199510010-00008. PMID:7661497
  • Darvishian M, Gefenaite G, Turner RM, Pechlivanoglou P, Van der Hoek W, Van den Heuvel ER, Hak E. After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly. J Clin Epidemiol. 2014;67:734–744. doi:10.1016/j.jclinepi.2014.02.009. PMID:24768004
  • Arriola CS, Garg S, Anderson EJ, Ryan PA, George A, Zansky SM, Bennett N, Reingold A, Bargsten M, Miller L, et al. Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza. Clin Infect Dis. 2017;65:1289–1297. doi:10.1093/cid/cix468. PMID:28525597
  • Mahmud SM, Bozat-Emre S, Hammond G, Elliott L, Van Caeseele P. Did the H1N1 Vaccine Reduce the Risk of Admission with Influenza and Pneumonia during the Pandemic? PLoS One. 2015;10:e0142754. doi:10.1371/journal.pone.0142754. PMID:26600435
  • Grijalva CG, Zhu Y, Williams DJ, Self WH, Ampofo K, Pavia AT, Stockmann CR, McCullers J, Arnold SR, Wunderink RG, et al. Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination. JAMA. 2015;314:1488–1497. doi:10.1001/jama.2015.12160. PMID:26436611
  • Arriola CS, Anderson EJ, Baumbach J, Bennett N, Bohm S, Hill M, Lindegren ML, Lung K, Meek J, Mermel E, et al. Does Influenza Vaccination Modify Influenza Severity? Data on Older Adults Hospitalized With Influenza During the 2012–2013 Season in the United States. J Infect Dis. 2015;212:1200–1208. doi:10.1093/infdis/jiv200. PMID:25821227
  • Simpson CR, Lone N, Kavanagh K, Ritchie LD, Robertson C, Sheikh A, McMenamin J. Seasonal Influenza Vaccine Effectiveness (SIVE): an observational retrospective cohort study – exploitation of a unique community-based national-linked database to determine the effectiveness of the seasonal trivalent influenza vaccine. Health Services and Delivery Research. 2013;1:1–45. doi:10.3310/hsdr01100.
  • Baxter R, Ray GT, Fireman BH. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine. 2010;28:7267–7272. doi:10.1016/j.vaccine.2010.08.088. PMID:20832494
  • Jackson ML, Nelson JC, Weiss NS, Neuzil KM, Barlow W, Jackson LA. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet. 2008;372:398–405. doi:10.1016/S0140-6736(08)61160-5. PMID:18675690
  • Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357:1373–1381. doi:10.1056/NEJMoa070844. PMID:17914038
  • Nordin J, Mullooly J, Poblete S, Strikas R, Petrucci R, Wei F, Rush B, Safirstein B, Wheeler D, Nichol KL. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis. 2001;184:665–670. doi:10.1086/323085. PMID:11517426
  • Crocetti E, Arniani S, Bordoni F, Maciocco G, Zappa M, Buiatti E. Effectiveness of influenza vaccination in the elderly in a community in Italy. Eur J Epidemiol. 2001;17:163–168. doi. doi:10.1023/A:1017978420601. PMID:11599691
  • Nichol KL. Complications of influenza and benefits of vaccination. Vaccine 1999;17(Suppl 1):S47–52. doi. doi:10.1016/S0264-410X(99)00105-X. PMID:10471180
  • Puig-Barberà J, Márquez-Calderón S, Masoliver-Fores A, Lloria-Paes F, Ortega-Dicha A, Gil-Martín M, Calero-Martínez MJ. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. J Epidemiol Community Health 1997;51:526–530. doi. doi:10.1136/jech.51.5.526. PMID:9425463
  • Ohmit SE, Monto AS. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. Int J Epidemiol 1995;24:1240–1248. doi. doi:10.1093/ije/24.6.1240. PMID:8824869
  • Mullooly JP, Bennett MD, Hornbrook MC, Barker WH, Williams WW, Patriarca PA, Rhodes PH. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994;121:947–952. doi. doi:10.7326/0003-4819-121-12-199412150-00008. PMID:7978721
  • Fedson DS, Wajda A, Nicol JP, Hammond GW, Kaiser DL, Roos LL. Clinical effectiveness of influenza vaccination in Manitoba. JAMA 1993;270:1956–1961. doi. doi:10.1001/jama.1993.03510160074032. PMID:8411553
  • Foster DA, Talsma A, Furumoto-Dawson A, Ohmit SE, Margulies JR, Arden NH, Monto AS. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992;136:296–307. doi. doi:10.1093/oxfordjournals.aje.a116495. PMID:1415151
  • Barker WH, Mullooly JP. Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths. JAMA 1980;244:2547–2549. doi. doi:10.1001/jama.1980.03310220045026. PMID:7431593
  • Song JY, Noh JY, Choi WS, Cheong HJ, Kim WJ. Antiviral therapy in seasonal influenza and 2009 H1N1 pandemic influenza: Korean experiences and perspectives. Expert Rev Anti Infect Ther. 2015;13:1361–1372. doi:10.1586/14787210.2015.1076334. PMID:26256778
  • Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:36–44. doi:10.1016/S1473-3099(11)70295-X. PMID:22032844
  • Hong KW, Cheong HJ, Choi WS, Lee J, Wie SH, Baek JH, Kim HY, Jeong HW, Kim WJ. Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011–2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillance. J Infect Chemother. 2014; 20:9–14. doi:10.1016/j.jiac.2013.07.001. PMID:24462445
  • Legrand J, Vergu E, Flahault A. Real-time monitoring of the influenza vaccine field effectiveness. Vaccine. 2006;24:6605–6611. doi: 10.1016/j.vaccine.2006.05.063.
  • Belongia EA, Skowronski DM, McLean HQ, Chambers C, Sundaram ME, De Serres G. Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Rev Vaccines. 2017;16:1–14. doi:10.1080/14760584.2017.1334554. PMID:28562111
  • Mannino S, Villa M, Apolone G, Weiss NS, Groth N, Aquino I, Boldori L, Caramaschi F, Gattinoni A, Malchiodi G, et al. Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol. 2012;176:527–533. doi:10.1093/aje/kws313. PMID:22940713
  • Van Buynder PG, Konrad S, Van Buynder JL, Brodkin E, Krajden M, Ramler G, Bigham M. The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly. Vaccine. 2013;31:6122–6128. doi:10.1016/j.vaccine.2013.07.059. PMID:23933368
  • Wilkinson K, Wei Y, Szwajcer A, Rabbani R, Zarychanski R, Abou-Setta AM, Mahmud SM. Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis. Vaccine. 2017;35:2775–2780. doi:10.1016/j.vaccine.2017.03.092. PMID:28431815
  • Moa AM, Chughtai AA, Muscatello DJ, Turner RM, MacIntyre CR. Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials. Vaccine. 2016;34:4092–4102. doi:10.1016/j.vaccine.2016.06.064. PMID:27381642
  • You JH, Ming WK, Chan PK. Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong. BMC Infect Dis. 2014;14:618. doi:10.1186/s12879-014-0618-9. PMID:25420713
  • Van Bellinghen LA, Meier G, Van Vlaenderen I. The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model. PLoS One. 2014;9:e98437. doi:10.1371/journal.pone.0098437. PMID:24905235

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.